Clinical Trials Directory

Trials / Completed

CompletedNCT05750485

Pupilometric Evaluation of Patients Under Procedural Sedation With Propofol

Pupilometric Evaluation of Nociception in Patients With Orthopedic Impairment Under Procedural Sedation With Propofol in the Context of the Use of the ALGISCAN Device in the Vital Emergency Department in Pasteur 2 Hospital, Nice France

Status
Completed
Phase
Study type
Observational
Enrollment
6 (actual)
Sponsor
Centre Hospitalier Universitaire de Nice · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Procedural sedation involves the administration of sedative medications that allow patients to tolerate painful procedures. Procedural sedation has been formally recommended by experts from the French Society of Emergency Medicine (SFMU) since 2010 and procedural sedation using propofol in emergency departments has been recommended by the American College of Emergency Physicians in 2018. Propofol monotherapy is now widely used in emergency medicine (EM) in France as part of procedural sedation for performing painful procedures, however propofol has no analgesic properties per se . Pupilometry makes it possible to study the depth of analgesia by evaluating the body's nociceptive response via the ANS by studying the pupil diameter. This technique would allow the evaluation of the analgesia level in patients sedated by PROPOFOL during the realization of painful procedures. Variations in pupil diameter during painful procedures under procedural sedation in an emergency department will be assesed in this study. Secondly, patients satisfaction following the procedure will also be evaluated by the use of the French version of the "ISAS-F", the Iowa Satisfaction with Anesthesia Scale.

Conditions

Interventions

TypeNameDescription
OTHERPupilometric evaluationPupilometric evaluation under procedural sedation with propofol

Timeline

Start date
2023-03-06
Primary completion
2023-05-31
Completion
2023-05-31
First posted
2023-03-01
Last updated
2025-04-08

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT05750485. Inclusion in this directory is not an endorsement.